An E-platform for Learners

Pharma News

Mazdutide, a Dual GLP-1/GCG Agonist, Demonstrates Superiority Over Semaglutide in Glycemic Control and Weight Loss for Type 2 Diabetes Patients

Mazdutide, a Dual GLP-1/GCG Agonist, Demonstrates Superiority Over Semaglutide in Glycemic Control and Weight Loss for Type 2 Diabetes Patients

Pharm'Up

Innovent Biologics announced that its fourth Phase 3 clinical trial, DREAMS-3, evaluating the novel drug mazdutide in...

Lupin Expands U.S. Footprint with New Corporate Headquarters in New Jersey

Lupin Expands U.S. Footprint with New Corporate Headquarters in New Jersey

Pharm'Up

Global pharmaceutical leader, Lupin Limited (Lupin), officially marked a major milestone in its United States operations with...

Merck’s Combo Therapy KEYTRUDA + WELIREG Hits Primary Endpoint in Kidney Cancer Adjuvant Trial (LITESPARK-022)

Merck’s Combo Therapy KEYTRUDA + WELIREG Hits Primary Endpoint in Kidney Cancer Adjuvant Trial (LITESPARK-022)

Pharm'Up

Merck (known as MSD outside North America) has announced positive top-line results from its Phase 3 LITESPARK-022...

Teva Settles QVAR Antitrust Case for $35 Million and Agrees to Withdraw Patents, Resolving Generic Delay Claims

Teva Settles QVAR Antitrust Case for $35 Million and Agrees to Withdraw Patents, Resolving Generic Delay Claims

Pharm'Up

Teva Pharmaceuticals USA, Inc., has agreed to a $35 million settlement to resolve a class action lawsuit...

Novel Antibody-Drug Conjugate Patritumab Deruxtecan Shows Strong Efficacy Against Active Brain Metastases

Novel Antibody-Drug Conjugate Patritumab Deruxtecan Shows Strong Efficacy Against Active Brain Metastases

Pharm'Up

An international Phase 2 clinical study, TUXEDO-3, led by the Medical University of Vienna, has yielded highly...

Researchers Uncover ‘Perineural Pathway’ Allowing HIV to Escape the Brain and Reseed the Body Despite Antiretroviral Therapy

Researchers Uncover ‘Perineural Pathway’ Allowing HIV to Escape the Brain and Reseed the Body Despite Antiretroviral Therapy

Pharm'Up

New research published in The American Journal of Pathology by investigators from Boston College and the Tulane...

UK Pioneers CAR T Cell Therapy for Multiple Sclerosis: Single-Dose ‘Immune Reset’ Targets Autoimmune Disease

UK Pioneers CAR T Cell Therapy for Multiple Sclerosis: Single-Dose ‘Immune Reset’ Targets Autoimmune Disease

Pharm'Up

A patient in the UK has become the first person to receive CAR T cell therapy (obecabtagene...

FDA Moves to Ban Unapproved Fluoride Pills and Drops for Children, Citing Microbiome Risk and Outdated Science

FDA Moves to Ban Unapproved Fluoride Pills and Drops for Children, Citing Microbiome Risk and Outdated Science

Pharm'Up

The U.S. Food and Drug Administration (FDA) has announced a major policy shift, taking action to restrict...

Semaglutide (Ozempic/Wegovy) Cuts Major Heart Risks Independent of Weight Loss, SELECT Trial Analysis Confirms

Semaglutide (Ozempic/Wegovy) Cuts Major Heart Risks Independent of Weight Loss, SELECT Trial Analysis Confirms

Pharm'Up

A recent research study conducted by University College London (UCL) has unveiled a groundbreaking finding from the...

Groundbreaking Approval Kygevvi Receives FDA Nod as First Treatment for TK2 Deficiency (TK2d)

Groundbreaking Approval Kygevvi Receives FDA Nod as First Treatment for TK2 Deficiency (TK2d)

Pharm'Up

The U.S. Food and Drug Administration (FDA) has announced a landmark decision, approving Kygevvi (doxecitine and doxribtimine)...